Dx Deals: Labcorp Continues Dealmaking with Incyte Asset Acquisition in Washington State
The majority of Labcorp’s revenue growth in the first quarter came from clinical lab acquisitions
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
The majority of Labcorp’s revenue growth in the first quarter came from clinical lab acquisitions
UPMC pathology leader discusses steps the lab takes to combat evolving cyber threats
Medical laboratories should monitor fraud cases across the country and also stay vigilant of suspicious patterns of behavior
Labcorp will acquire oncology-related clinical tests services from BioReference’s parent company, OPKO Health
Read this overview of legislation and regulations governing laboratory marketing practices and learn tips to ensure these activities remain compliant
As of March 1, 2026, CMS will move CLIA away from paper-based transactions to improve efficiency and payments
The board was eliminated as part of a sweeping reordering of the Department of Health and Human Services
A lawyer advises medical laboratories on how to improve their avenues for reporting unethical behavior
A leaked budget document for the next fiscal year suggested non-user fee funding may be up slightly compared to recent years.
The role at this point is theoretical, but our editors asked AI for help in drafting what the position might entail
While still in the early stages, Clinical Lab 2.0’s pitch for this new position fits with the need to better use lab data